Jyväskylä Central Hospital Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2017
NCT03236961
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Jyväskylä Central Hospital